Cite

HARVARD Citation

    Brightling, C. et al. (2021). The pharmacology of the prostaglandin D2 receptor 2 (DP2) receptor antagonist, fevipiprant. Pulmonary pharmacology & therapeutics. p. . [Online]. 
  
Back to record